Semaglutide for teens and adults with genetic obesity
Part of Hormones & metabolism clinical trials.
This study looks at how semaglutide works in real life for people with obesity caused by a single gene change. If you or your teenager have this type of obesity and are taking or about to start semaglutide, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years or older
- You have already started semaglutide treatment or your doctor has decided to start it
- You have a confirmed type of obesity linked to a specific gene change (monogenic obesity)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether semaglutide (a once-weekly injection) helps adolescents with a specific genetic form of obesity lose weight. It is for teens who are already being prescribed semaglutide as part of their regular care.
This study looks at how teenagers and young adults respond to weight-loss surgery (sleeve gastrectomy) and whether adding a medication called semaglutide can help improve weight loss. It has two parts: first observing how surgery affects you, then testing if semaglutide helps those who didn't lose enough weight after surgery.
This trial studies how the body adapts to weight loss in teens with obesity. You will either get a behavioral lifestyle program alone or with a weight loss medication called semaglutide.
This study tests a medication called semaglutide (a once-a-week injection) to help teenagers with autism who have obesity lose weight and improve their body composition. It compares their results to a group of similar teens who didn't take the drug.
This study tests a weight loss program that combines a weekly medicine injection with lifestyle coaching for teens with obesity. It aims to help teens achieve a healthier weight and improve overall wellness.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
Hear when a new Monogenic Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.